Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Raxibacumab (ABthrax), a human IgG1 monoclonal antibody, targets the protective antigen (PA) of Bacillus anthracis. It inhibits the toxic impact of anthrax by obstructing the PA's attachment to host cell receptors, preventing the subsequent harmful effects. This compound is utilized in anti-anthrax research [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Raxibacumab (ABthrax), a human IgG1 monoclonal antibody, targets the protective antigen (PA) of Bacillus anthracis. It inhibits the toxic impact of anthrax by obstructing the PA's attachment to host cell receptors, preventing the subsequent harmful effects. This compound is utilized in anti-anthrax research [1] [2]. |
In vivo | Raxibacumab, administered intravenously at doses of 150 μg/kg or 300 μg/kg in a single dose, significantly improved the prognosis in rats when given within 6 hours after initial exposure to lethal anthrax toxin (LeTx) [3]. |
Synonyms | ABthrax |
Molecular Weight | N/A |
CAS No. | 565451-13-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Raxibacumab 565451-13-0 ABthrax inhibitor inhibit